Home Your basket
• Guidelines for the clinic...
   Price 12.50 €
• Notes on voice and speech...
   Price 8.50 €
• Orbital decompression in ...
   Price 10.50 €
• Role of positron emission...
   Price 15.00 €
• Reconstruction after tumo...
   Price 10.50 €
• Hygiene and sterilisation...
   Price 10.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Rhinophyma in a black afr...
   Price 5.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• The sound intensity after...
   Price 10.50 €
• Objective analysis of pos...
   Price 8.50 €
• Thyroid differenciated ca...
   Price 10.50 €
• Adenocarcinoma of the end...
   Price 8.50 €
• Toxic nodular goitre asso...
   Price 5.50 €
• Ethmoidal metastasis reve...
   Price 8.50 €
• Improving quality of life...
   Price 12.00 €
• Objective tinnitus and es...
   Price 5.50 €
• Arteriovenous haemangioma...
   Price 8.50 €
• Evaluation of the presenc...
   Price 12.50 €
• Management of cervical ce...
   Price 10.50 €
• Mastoid eosinophilic gran...
   Price 5.50 €
• Cutaneous horn of the pin...
   Price 5.50 €
• The value of fine-needle ...
   Price 10.50 €
• Vestibular-evoked myogeni...
   Price 10.50 €
• Sarcomatoid carcinomas of...
   Price 10.50 €
• Nasal tumours of the thre...
   Price 10.50 €
• An important procedure in...
   Price 8.50 €
• The effectiveness of voic...
   Price 14.00 €
• Peptide receptor radionuc...
   Price 14.00 €
• Papillary thyroid microca...
   Price 10.50 €

Total Order 285.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2015 o

RHINOLOGY

External versus endoscopic approach in the manage­ment of 131 sinonasal inverted papillomas


Authors : Larget I, Bastier PL, De Gabory L. (Bordeaux)

Ref. : Rev Laryngol Otol Rhinol. 2015;136,1:3-7.

Article published in english
Downloadable PDF document english



Summary : Background: Incidence of inverted Papilloma (IP) is around 0.5% to 4% of all nasal tumours. It is characterised by its propensy for local invasiveness, recurrence and malignant trans­formation. The treatment of reference is surgery. The aim of our study was to compare our oncologic outcome and morbidity between the open and the endoscopic approach to remove inverted papillomas. Material and method: This retrospective study includes all primary and benign cases operated between 1985 and 2012. We assessed epidemiologic data, medical history, tumour location, morbidity of treatment, pathological outcomes, patient’s follow-up and rate of recurrence. The mean time of surgery, of follow-up and recurrence delay were compared. Results: 131 patients were included: 77 operated by lateral rhinotomy or mid-facial degloving and 54 by endoscopic approach (± associated with a limited Caldwell-Luc or a frontal incision). The mean time of surgery for the endoscopic approach was 76 ± 46 min (10-240 min) vs 163 ± 46 min (60-300 min) for the open approach (p< 10-5). The uncinate process was included in most of the IP (97/131; 74%), including its horizontal and/or vertical parts. The mean follow-up in endoscopic group was 43 ± 32 months (12-177 months) vs 73 ± 48 months (12-221 months) for the open approach group (p< 10-4). The recurrence rates are not significantly different for both groups: 9% (7/77) after open approach vs 7.4% (4/54) after endoscopic approach (p> 0.05). Also, the mean delay of recurrence was not different between both group (p> 0.05) and the propensy of recurrence didn’t depend on the degree of dysplasia. There were fewer compli­ca­tions in the endoscopic group (13%) than in the open approach group (57%). Conclusion: According to several authors we found no statistical difference on the oncological outcome between surgery via open versus endoscopic approach to remove IP. Endoscopic surgery offers less complications and morbidity than external approach.


Price : 14.00 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE